Stocks · Health care · Pharmaceutical Preparations

Edesa Biotech, Inc.

EDSA Clue Score49
British Columbia, Canada Fiscal year ends September CIK 0001540159 Results filed 13 Aug 2026

What the insiders did Net buying

By person

9 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Pardeep Nijhawan
Chief Executive Officer
$229.91K (8)
—
+$229.91K
1,875,402
$12.38M
+88.5%
Michael J Brooks
President
$3.14K (1)
—
+$3.14K
291,479
$1.92M
+1,550%
Peter J. Weiler
Chief Financial Officer
—
—
—
129,609
$855.28K
—
Patrick Marshall
Director
—
—
—
71,666
$472.92K
—
Carlo Sistilli
Director
—
—
—
49,417
$326.10K
—
Sean Arthur MacDonald
Director
—
—
—
41,054
$270.91K
+1,900%
Joan Chypyha
Director
—
—
—
30,029
$198.16K
+103,448%
Charles Olson V
Director
—
—
—
30,000
$197.97K
—
Da David Liu
Director
—
—
—
24,501
$161.68K
—

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 3,467,658 to 9,641,031 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.